09.09.2026, 17:46

Promomed launches flagship drug in Kazakhstan

MOSCOW. Sept 9 (Interfax) – Kazakhstan's Health Ministry has granted Promomed a registration certificate for its tirzepatide-based drug, used to treat type 2 diabetes and obesity, the Russian pharmaceutical company said.

To read the full news articles, Subscribe.

03:57PM
AVERAGE WEIGHTED RATE ON SEPTEMBER 10, 2026 IS 450.79 TENGE FOR $1

03:22PM
QazaqGaz explores borrowing options on Hong Kong capital markets

02:04PM
Lack of incentives holds back Kazakh businesses from IPOs – expert

01:48PM
Tajikistan expects to achieve energy independence after Rogun HPP's Unit 3 launch in 2027 - Rahmon

01:46PM
Tajik, Kazakh officials discuss preparations for intergovernmental commission meeting

01:24PM
Tokayev congratulates new King of Norway on accession to throne

01:19PM
Turkmen president, EU ambassador discuss bilateral cooperation priorities

01:18PM
Kyrgyzstan to severely punish corruption, spreading fake news - president

01:17PM
Two Kazakh transport officials detained on corruption suspicion

12:29PM
Kazakh parliament pushes for tighter gasoline quality controls

11:55AM
Kazakh railway operator reaffirms plans for 2026 IPO

11:45AM
Kazakhstan's new parliament approves rules of procedure

11:20AM
Kazakh companies join new EAEU projects

11:08AM
Kazakhstan advocates global peace efforts, China's role crucial – Tokayev

10:19AM
Tokayev congratulates Rybakina on becoming world No. 1

Press center

https://press.interfax.kz

WE EXPECT A SURGE IN INFLATION IN EARLY 2026 DUE TO TAX REFORM, BUT IT WILL BE ABSORBED BY YEAR-END

KAZAKHSTAN TO ACHIEVE FULL DAIRY SELF-SUFFICIENCY BY 2027, BUT IMPORTS STILL NEEDED

KAZAKHSTAN CAN BECOME A REGIONAL LEADER IN MINERAL EXPLORATION

COUNTRIES TRYING TO BE FRIENDLY WITH EVERYONE CAN BENEFIT AND BECOME MORE ATTRACTIVE FOR INVESTMENT

Promomed launches flagship drug in Kazakhstan

Press center